Pfizer (PFE) Short Interest Ratio & Short Volume

Short interest is the volume of Pfizer shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 62,510,000 shares of PFE short. Learn More on Pfizer's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PFE shares currently have a short interest ratio of 2.0. Learn More on Pfizer's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pfizer: CMT Capital Markets Trading GmbH, BlueCrest Capital Management Ltd, Capital Markets Trading UK LLP, Torno Capital LLC, PEAK6 Investments LLC, National Bank of Canada FI, HAP Trading LLC, JPMorgan Chase & Co., XR Securities LLC, SG Americas Securities LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Caas Capital Management LP, Oak Hill Wealth Advisors LLC, Simplex Trading LLC, IMC Chicago LLC, Curated Wealth Partners LLC, Private Capital Management LLC, Nomura Holdings Inc., and Readystate Asset Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Pfizer saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 62,510,000 shares, a decline of 8.2% from the previous total of 68,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Pfizer: Bristol-Myers Squibb (1.38%), Zoetis Inc. (1.13%), AbbVie Inc. (0.82%), Merck & Co., Inc. (0.74%), Johnson & Johnson (0.74%), Abbott Laboratories (0.84%), Sanofi (0.22%), Vertex Pharmaceuticals Incorporated (1.50%), Novartis AG (0.22%), Regeneron Pharmaceuticals, Inc. (1.42%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

Short selling PFE is an investing strategy that aims to generate trading profit from Pfizer as its price is falling. PFE shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Pfizer occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PFE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PFE, twice per month. The most recent reporting period available is April, 30 2024.